Ora is a leading full-service ophthalmic drug and device development firm dedicated to advancing the future of ophthalmic clinical research. With over 45 years of experience, Ora has successfully guided clients through all phases of clinical research, resulting in more than 85 new product approvals. The company employs over 600 professionals across North America, Europe, Asia, and Latin America, leveraging unique methodologies and integrated clinical data solutions to optimize the development and market introduction of innovative therapies. Ora is committed to fostering a culture of kindness, operational excellence, joy, and scientific rigor, while promoting diversity and inclusion within its workforce.